Follow
Michael D. Radmacher
Michael D. Radmacher
Bioinformatics Research Scientist
Verified email at AsterInsights.com
Title
Cited by
Cited by
Year
Molecular classification of cutaneous malignant melanoma by gene expression profiling
M Bittner, P Meltzer, Y Chen, Y Jiang, E Seftor, M Hendrix, M Radmacher, ...
Nature 406 (6795), 536-540, 2000
25722000
Gene-expression profiles in hereditary breast cancer
I Hedenfalk, D Duggan, Y Chen, M Radmacher, M Bittner, R Simon, ...
New England Journal of Medicine 344 (8), 539-548, 2001
21512001
Pitfalls in the use of DNA microarray data for diagnostic and prognostic classification
R Simon, MD Radmacher, K Dobbin, LM McShane
Journal of the National Cancer Institute 95 (1), 14-18, 2003
12022003
IDH1 and IDH2 gene mutations identify novel molecular subsets within de novo cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B study
G Marcucci, K Maharry, YZ Wu, MD Radmacher, K Mrózek, D Margeson, ...
Journal of clinical oncology 28 (14), 2348, 2010
9472010
pH Regulates Genes for Flagellar Motility, Catabolism, and Oxidative Stress in Escherichia coli K-12
LM Maurer, E Yohannes, SS Bondurant, M Radmacher, JL Slonczewski
Journal of bacteriology 187 (1), 304-319, 2005
5432005
MicroRNA expression in cytogenetically normal acute myeloid leukemia
G Marcucci, MD Radmacher, K Maharry, K Mrózek, AS Ruppert, ...
New England Journal of Medicine 358 (18), 1919-1928, 2008
5382008
Design and analysis of DNA microarray investigations
RM Simon, EL Korn, LM McShane, MD Radmacher, GW Wright, Y Zhao
Springer, 2003
5172003
An 86-probe-set gene-expression signature predicts survival in cytogenetically normal acute myeloid leukemia
KH Metzeler, M Hummel, CD Bloomfield, K Spiekermann, J Braess, ...
Blood, The Journal of the American Society of Hematology 112 (10), 4193-4201, 2008
4432008
TET2 mutations improve the new European LeukemiaNet risk classification of acute myeloid leukemia: a Cancer and Leukemia Group B study
KH Metzeler, K Maharry, MD Radmacher, K Mrózek, D Margeson, ...
Journal of clinical oncology 29 (10), 1373, 2011
4262011
Favorable prognostic impact of NPM1 mutations in older patients with cytogenetically normal de novo acute myeloid leukemia and associated gene-and microRNA-expression …
H Becker, G Marcucci, K Maharry, MD Radmacher, K Mrózek, ...
Journal of clinical oncology 28 (4), 596, 2010
4242010
Prognostic significance of, and gene and microRNA expression signatures associated with, CEBPA mutations in cytogenetically normal acute myeloid leukemia with high-risk …
G Marcucci, K Maharry, MD Radmacher, K Mrózek, T Vukosavljevic, ...
Journal of clinical oncology 26 (31), 5078, 2008
3772008
FLT3 D835/I836 mutations are associated with poor disease-free survival and a distinct gene-expression signature among younger adults with de novo cytogenetically normal …
SP Whitman, AS Ruppert, MD Radmacher, K Mrózek, P Paschka, ...
Blood, The Journal of the American Society of Hematology 111 (3), 1552-1559, 2008
3582008
A paradigm for class prediction using gene expression profiles
MD Radmacher, LM McShane, R Simon
Development, 2018
3472018
ASXL1 mutations identify a high-risk subgroup of older patients with primary cytogenetically normal AML within the ELN Favorable genetic category
KH Metzeler, H Becker, K Maharry, MD Radmacher, J Kohlschmidt, ...
Blood, The Journal of the American Society of Hematology 118 (26), 6920-6929, 2011
3462011
Age-related prognostic impact of different types of DNMT3A mutations in adults with primary cytogenetically normal acute myeloid leukemia
G Marcucci, KH Metzeler, S Schwind, H Becker, K Maharry, K Mrózek, ...
Journal of clinical oncology 30 (7), 742, 2012
3422012
RUNX1 mutations are associated with poor outcome in younger and older patients with cytogenetically normal acute myeloid leukemia and with distinct gene and MicroRNA expression …
JH Mendler, K Maharry, MD Radmacher, K Mrózek, H Becker, ...
Journal of clinical oncology 30 (25), 3109, 2012
3332012
The prognostic and functional role of microRNAs in acute myeloid leukemia
G Marcucci, K Mrózek, MD Radmacher, R Garzon, CD Bloomfield
Blood, The Journal of the American Society of Hematology 117 (4), 1121-1129, 2011
3152011
Overexpression of the ETS-related gene, ERG, predicts a worse outcome in acute myeloid leukemia with normal karyotype: a Cancer and Leukemia Group B study
G Marcucci, CD Baldus, AS Ruppert, MD Radmacher, K Mrózek, ...
J Clin Oncol 23 (36), 9234-9242, 2005
3012005
Methods for assessing reproducibility of clustering patterns observed in analyses of microarray data
LM McShane, MD Radmacher, B Freidlin, R Yu, MC Li, R Simon
Bioinformatics 18 (11), 1462-1469, 2002
2952002
Sp1/NFκB/HDAC/miR-29b regulatory network in KIT-driven myeloid leukemia
S Liu, LC Wu, J Pang, R Santhanam, S Schwind, YZ Wu, CJ Hickey, J Yu, ...
Cancer cell 17 (4), 333-347, 2010
2872010
The system can't perform the operation now. Try again later.
Articles 1–20